Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP46A1 | Q9Y6A2 | 2/20 | 0.77 |
| ▸ | POLA1 | P09884 | 1/20 | 0.76 |
| ▸ | OSBP | P22059 | 4/20 | 0.75 |
| ▸ | RORC | P51449 | 3/20 | 0.75 |
| ▸ | USP2 | O75604 | 2/20 | 0.75 |
| ▸ | OSBP2 | Q969R2 | 2/20 | 0.75 |
| ▸ | LMNA | P02545 | 1/20 | 0.75 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.75 |
| ▸ | ACHE | P22303 | 1/20 | 0.69 |
| ▸ | EBP | Q15125 | 1/20 | 0.69 |
| ▸ | DHCR7 | Q9UBM7 | 1/20 | 0.69 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.64 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.64 |
| ▸ | NR1H3 | Q13133 | 3/20 | 0.64 |
| ▸ | GBA1 | P04062 | 2/20 | 0.63 |
| ▸ | UGCG | Q16739 | 2/20 | 0.63 |
| ▸ | GBA2 | Q9HCG7 | 2/20 | 0.63 |
| ▸ | NPC1L1 | Q9UHC9 | 3/20 | 0.61 |
| ▸ | CRYAB | P02511 | 1/20 | 0.61 |
| ▸ | HMGCR | P04035 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20459397 | 1.00 | CYP46A1 (0.77) | CYP46A1POLA1OSBPRORCUSP2 | |
| SCHEMBL22013894 | 1.00 | CYP46A1 (0.77) | CYP46A1POLA1OSBPRORCUSP2 | |
| SCHEMBL15150903 | 1.00 | CYP46A1 (0.77) | CYP46A1POLA1OSBPRORCUSP2 | |
| SCHEMBL17663640 | 1.00 | CYP46A1 (0.77) | CYP46A1POLA1OSBPRORCUSP2 | |
| SCHEMBL12940685 | 1.00 | CYP46A1 (0.77) | CYP46A1POLA1OSBPRORCUSP2 | |
| SCHEMBL24405093 | 1.00 | CYP46A1 (0.77) | CYP46A1POLA1OSBPRORCUSP2 | |
| SCHEMBL20924867 | 1.00 | CYP46A1 (0.77) | CYP46A1POLA1OSBPRORCUSP2 | |
| SCHEMBL22389093 | 1.00 | CYP46A1 (0.77) | CYP46A1POLA1OSBPRORCUSP2 | |
| SCHEMBL21707464 | 1.00 | CYP46A1 (0.77) | CYP46A1POLA1OSBPRORCUSP2 | |
| SCHEMBL12896265 | 1.00 | CYP46A1 (0.77) | CYP46A1POLA1OSBPRORCUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115286676-B | Synthesis method for preparing cholesterol methyl ether from diosgenin | 沈阳化工研究院有限公司 | 2023-07-07 | — | — | CN | claimed |
| CN-115286676-A | Synthetic method for preparing cholesterol methyl ether from diosgenin | 沈阳化工研究院有限公司 | 2022-11-04 | — | — | CN | claimed |
| CN-109701028-A | D configuration T7 peptide modified matrix material, wherein mesosome, drug delivery system and their preparation method and purposes | 四川大学 | 2019-05-03 | — | — | CN | claimed |
| EP-4628893-A2 | COMPOSITIONS AND METHODS FOR REMOVING INTERFERING SUBSTANCES | Siemens Healthcare Diagnostics, Inc. (US) | 2025-10-08 | — | — | EP | disclosed |
| EP-3856149-B1 | COMPOSITIONS AND METHODS FOR REMOVING INTERFERING SUBSTANCES | SIEMENS HEALTHCARE DIAGNOSTICS INC (US) | 2025-07-30 | — | — | EP | disclosed |
| US-20250138001-A1 | Liposome-containing Diagnostic Reagents and Methods of Production and Use Thereof | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2025-05-01 | — | — | US | disclosed |
| US-20250102404-A1 | COMPOSITIONS AND METHODS FOR REMOVING INTERFERING SUBSTANCES | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2025-03-27 | — | — | US | disclosed |
| US-12203831-B2 | Compositions and methods for removing interfering substances | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2025-01-21 | — | — | US | disclosed |
| EP-4490519-A1 | LIPOSOME-CONTAINING DIAGNOSTIC REAGENTS AND METHODS OF PRODUCTION AND USE THEREOF | Siemens Healthcare Diagnostics, Inc. (US) | 2025-01-15 | — | — | EP | disclosed |
| CN-118901013-A | Diagnostic agents containing liposomes, methods of production and uses thereof | 美国西门子医学诊断股份有限公司 | 2024-11-05 | — | — | CN | disclosed |
| US-11918770-B2 | Implants for localized drug delivery and methods of use thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-03-05 | — | — | US | disclosed |
| WO-1995002424-A1 | LOCALIZATION AND THERAPY OF NON-PROSTATIC ENDOCRINE CANCER WITH AGENTS DIRECTED AGAINST PROSTATE SPECIFIC ANTIGEN | NORDION INTERNATIONAL INC. (CA) | 1995-01-26 | — | — | WO | disclosed |
| US-4929603-A | ANTICHOLESTEROL AGENTS, CARDIOVASCULAR DISORDERS | ROOPERAL (NA) NV | 1990-05-29 | — | — | US | disclosed |
| EP-0151385-B1 | USE OF PHYTOSTEROLGLYCOSIDES FOR THE PREPARATION OF MEDICAMENTS FOR TREATMENT OF ELEVATED 5(6)ALPHA-EPOXYCHOLESTEROL LEVELS | ROOPEROL (NA) NV (NL) | 1989-04-19 | — | — | EP | disclosed |
| EP-0151385-A2 | Use of phytosterolglycosides for the preparation of medicaments for treatment of elevated 5(6)alpha-epoxycholesterol levels | ROOPEROL (NA) NV (NL) | 1985-08-14 | — | — | EP | disclosed |
| EP-0077555-B1 | METHOD FOR THE PURIFICATION OF CHOLESTEROL OXIDASE | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1985-08-07 | — | — | EP | disclosed |
| EP-0077555-A2 | Method for the purification of cholesterol oxidase | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1983-04-27 | — | — | EP | disclosed |
| US-4374930-A | ADSORPTION ON STEROID, ELUTION, SURFACTANT | EASTMAN KODAK COMPANY (US) | 1983-02-22 | — | — | US | disclosed |
| US-4170518-A | Microbiological conversion of sterol derivatives to 5-androsten-17-one derivatives and their use | SCHERING AKTIENGESELLSCHAFT (DE) | 1979-10-09 | — | — | US | disclosed |
| US-3975287-A | Liquid crystal composition for electric field indication | KANSAI PAINT COMPANY, LTD. (JA) | 1976-08-17 | — | — | US | disclosed |